Prognostic value of pretreatment metabolic pet parameters in cervical cancer patients with metabolic complete response after concurrent chemoradiotherapy

Seung Hyun Son, Shin Young Jeong, Gun Oh Chong, Yoon Hee Lee, Shin Hyung Park, Chang Hee Lee, Chae Moon Hong, Ju Hye Jeong, Sang Woo Lee, Byeong Cheol Ahn, Jaetae Lee

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Abstract

Purpose Cervical cancer may recur after concurrent chemoradiotherapy (CCRT), even in patients with metabolic complete response (mCR) on post-CCRT 18F-FDG PET. We retrospectively analyzed the value of metabolic parameters, measured by pretreatment PET, as prognostic factors for predicting recurrence and death in cervical cancer patients with mCR. Methods In 61 patients who reached mCR on post-CCRT, metabolic PET parameters including SUVmax, metabolic tumor volume (MTV), and total lesion glycolysis (TLG) of the primary tumors, as well as those of the metastatic lymph nodes, were measured by pre-CCRT PET. Total MTV and total TLG were also measured from primary tumors and metastatic lymph nodes. Survival analyses for disease-free survival (DFS) and overall survival (OS) were performed. Results Eleven patients (18.0%) presented with recurrence of cervical cancer, and 12 (19.7%) died during follow-up. SUVmax, MTV, TLG of metastatic lymph nodes, and total TLG could significantly predict DFS, and nodal SUVmax could predict OS. Para-aortic lymph node metastasis also significantly correlated with both DFS and OS. In multivariate analysis, nodal SUVmax and para-aortic lymph nodes metastasis were prognostic factors for DFS, and the best predictor was nodal SUVmax. For OS, nodal MTV and para-aortic lymph node metastasis were significant prognostic factors in multivariate analysis, and the best predictor was para-aortic lymph node metastasis. Conclusions Metabolic PET parameters, SUVmax or MTV values of metastatic lymph nodes, may be surrogate prognostic markers for recurrence or death in patients with locally advanced cervical cancer who reached mCR after definitive CCRT.

Original languageEnglish
Pages (from-to)e296-e303
JournalClinical Nuclear Medicine
Volume43
Issue number9
DOIs
StatePublished - 1 Sep 2018

Keywords

  • CCRT
  • cervical cancer
  • concurrent chemoradiotherapy
  • metabolic complete response
  • metabolic PET parameter
  • prognosis

Fingerprint

Dive into the research topics of 'Prognostic value of pretreatment metabolic pet parameters in cervical cancer patients with metabolic complete response after concurrent chemoradiotherapy'. Together they form a unique fingerprint.

Cite this